NASDAQ · Biotechnology

ABVC (ABVC) Stock

$1.04 -3.70% NASDAQ: ABVC Healthcare

Valuation

MetricValue
Price$1.04
Market Cap$15.07M
P/E Ratio-2.82
P/B Ratio1.45
P/S Ratio0.00
EPS (TTM)$-0.39
52-Week High$5.48
52-Week Low$0.88
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-72.73%
ROA-38.10%
ROCE-53.85%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.25
Current Ratio0.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$1.0M$0$1.0M$0
Operating Profit$-12.0M$-15.0M$-7.0M$-5.0M$-7.0M
Net Profit$-13.0M$-16.0M$-8.0M$-5.0M$-8.0M
EPS$-5.10$-5.20$-1.80$-0.42$-0.39
Op Margin-3290.1%-1558.5%-4439.2%-923.3%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$14.0M$11.0M$8.0M$8.0M$21.0M
Total Liabilities$5.0M$6.0M$7.0M$7.0M$8.0M
Cash$6.0M$1.0M$1.0M$1.0M$1.0M
Borrowings$3.0M$3.0M$3.0M$3.0M$3.0M

Latest News

ABVC BioPharma, Inc. Announces Planned Spin-Off of BioKey (Cayman), Inc. Through Dividend Distribution of BioKey Shares to ABVC Shareholders NewMediaWire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-8.0M$-7.0M$-4.0M$-2.0M$-3.0M
Investing Cash Flow$-1.0M$-2.0M$0$0$-1.0M
Financing Cash Flow$-1.0M$0$3.0M$2.0M$0
Net Cash Flow$2.0M$-5.0M$-1.0M$0$0
Free Cash Flow$-8.0M$-8.0M$-4.0M$-2.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-0.39%
Quick Ratio0.12
Interest Coverage—
Return 1Y-64.15%
Return 3Y-69.52%
Return 5Y-97.44%

Ownership

Insiders Held18.57%
Institutions Held3.14%
Institutions Float Held3.86%
Institutional HolderSharesReport Date
Geode Capital Management, LLC221,1692026-03-31
Vanguard Capital Management LLC190,5742026-03-31
Vanguard Fiduciary Trust Co97,3632026-03-31
Renaissance Technologies, LLC95,1002026-03-31
State Street Corporation72,8002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATNM $0.80 +1.32% -1.07 $25.02M 0.00%
FGENFibroGen, Inc. $9.07 -1.63% 0.22 $36.69M 0.00%
GRCE $2.37 +3.04% -2.26 $38.57M 0.00%
JUNSJupiter Neurosciences, Inc. $0.11 -5.37% -0.45 $4.16M 0.00%
LTRN $2.63 -0.75% -2.02 $33.56M 0.00%

About ABVC

ABVC is led by CEO Uttam Yashwant Patil, employs 16 people, headquartered in US, publicly traded since 2004.

ABVC stock trades at $1.04 with a market capitalization of $15.07M. The stock is valued at a price-to-earnings (P/E) ratio of -2.82, price-to-book of 1.45, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.88 and $5.48, and currently trades 81.0% below its 52-week high.

On profitability, ABVC generates a return on equity (ROE) of -72.73%, return on capital employed of -53.85%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides